Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathways

Title
Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathways
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 108, Issue -, Pages 297-308
Publisher
Elsevier BV
Online
2018-09-16
DOI
10.1016/j.biopha.2018.08.145

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started